jlightner

Tekton Research Adds Two New Sites to Expand Neuroscience and General Medicine Capabilities in Key U.S. Markets

by

Growth strengthens Tekton’s regional density and enhances access to diverse patient populations AUSTIN, TX – Tekton Research, a leading multi-site clinical trial organization, today announced the addition of two new research sites in New Carlisle, Ohio, and Englewood, New Jersey. The expansion supports Tekton’s continued growth in Neuroscience and General Medicine research while deepening access … Read more

Understanding Lennox-Gastaut Syndrome (LGS)

by

Lennox-Gastaut Syndrome (LGS) is a severe form of epilepsy that typically develops in early childhood and often leads to lifelong challenges. LGS evolves over time, most commonly emerging between ages 1 and 8. While rare, it affects approximately one in every 2,000 individuals (source: LGS Foundation), with about 50,000 people in the United States and … Read more

Corey A. Collins Promoted to CEO of Tekton Research to Lead Next Era of Growth

by

Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic Research AUSTIN, TX – October 2, 2025 — Tekton Research, a leading multi-site clinical trial company, is pleased to announce the promotion of Corey A. Collins to Chief Executive Officer (CEO). Collins joined Tekton in December 2023 as Chief Financial Officer, bringing over 20 years of … Read more

Tekton Research Expands with Three New Sites, Five New Investigators, and CNS Thought Leader

by

Growth supports Tekton’s strategic focus on CNS and Cardiometabolic research AUSTIN, TX – September 26, 2025 — Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its expanding network. These additions reflect Tekton’s continued commitment … Read more

Why Rare Disease Trials Are Different: Challenges and Opportunities

by
Why Rare Disease Trials Are Different Challenges and Opportunities

When it comes to clinical research, no two studies are exactly alike—but rare disease trials stand in a category of their own. Though each condition may affect only a small number of people, together rare diseases impact an estimated 300 million patients worldwide. For these individuals and families, research often represents the only pathway to … Read more

How Clinical Trials Are Powering the Future of Alzheimer’s Care

by

Alzheimer’s Disease remains one of the most pressing public health challenges of our time. Affecting over 6 million Americans, this progressive neurological disorder not only takes a profound toll on individuals and their families–it also places a significant burden on healthcare systems worldwide. While there is no cure yet, hope is on the horizon–and clinical … Read more

How Obesity Impacts Chronic Diseases: A Closer Look

by

Obesity is more than a number on a scale–it’s a chronic disease that significantly increases the risk of developing long-term health conditions. At Tekton Research, we’re committed to advancing research in obesity because we know it’s at the core of a larger health crisis. Understanding and treating obesity isn’t just about weight loss, it’s about … Read more

Digital Health in Clinical Research: Wearables, Apps, and Diagnostic Device Research

by
Digital Health in Clinical Research Device Trials

From continuous glucose monitors to heart rate sensors, the tools patients use to monitor their health have never been more advanced—or more essential. At Tekton, we’re proud to conduct clinical trials for diagnostic devices and health technology that help shape the future of care. Whether it’s validating a new temperature thermometer, testing a next-generation continuous … Read more